{"schema_version":"secwatch.filing_event.v1","accession":"0001850902-26-000007","form_type":"8-K","ticker":"TKNO","cik":"0001850902","company_name":"Alpha Teknova, Inc.","filed_at":"2026-05-06T23:59:59+00:00","discovered_at":"2026-05-14T18:02:33.130343+00:00","generated_at":"2026-05-14T22:54:12.418267+00:00","sec_items":["2.02","9.01","5.05"],"event_type":"earnings","sentiment":"positive","materiality_score":0.7,"confidence":"high","headline":"Teknova Q1 revenue $11.1M (+13% YoY); reaffirms FY 2026 guidance $42-44M","bullets":["Total revenue $11.1M, up 13% YoY; Clinical Solutions revenue surged 85% to $2.1M.","Net loss $4.6M (diluted EPS -$0.08) vs $4.6M; Adjusted EBITDA improved to -$2.0M from -$2.5M.","Gross margin expanded to 34.2% from 30.7%; Free Cash Outflow improved to $3.6M from $4.3M.","Reaffirmed FY 2026 revenue guidance $42-44M and Free Cash Outflow under $10M.","Cash and short-term investments $17.8M; total borrowings $13.2M at quarter end."],"urls":{"canonical":"https://secwatch.observer/filing/0001850902-26-000007","json":"https://secwatch.observer/filing/0001850902-26-000007.json","markdown":"https://secwatch.observer/filing/0001850902-26-000007.md","text":"https://secwatch.observer/filing/0001850902-26-000007.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1850902/000185090226000007/0001850902-26-000007-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1850902/000185090226000007/tkno-20260504.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-14T22:54:12.418267+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}